海南海灵化学制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
151
NMPA:151
Drug Approvals
Cefoperazone Sodium and Sulbactam Sodium for Injection
- Product Name
- 注射用头孢哌酮钠舒巴坦钠
- Approval Number
- 国药准字H20258085
- Approval Date
- May 23, 2025
NMPA
Cefoperazone Sodium and Sulbactam Sodium for Injection
- Product Name
- 注射用头孢哌酮钠舒巴坦钠
- Approval Number
- 国药准字H20258086
- Approval Date
- May 23, 2025
NMPA
Lidocaine and Prilocaine Cream
- Product Name
- 利丙双卡因乳膏
- Approval Number
- 国药准字H20249736
- Approval Date
- Dec 17, 2024
NMPA
Ceftazidime and Avibactam Sodium for Injection
- Product Name
- 注射用头孢他啶阿维巴坦钠
- Approval Number
- 国药准字H20249571
- Approval Date
- Dec 1, 2024
NMPA
Caspofungin Acetate for Injection
- Product Name
- 注射用醋酸卡泊芬净
- Approval Number
- 国药准字H20203001
- Approval Date
- Oct 18, 2024
NMPA
Cefotaxime Sodium for Injection
- Product Name
- 注射用头孢噻肟钠
- Approval Number
- 国药准字H20247187
- Approval Date
- Aug 8, 2024
NMPA
Cefazolin Sodium for Injection
- Product Name
- 注射用头孢唑林钠
- Approval Number
- 国药准字H20247174
- Approval Date
- Jul 26, 2024
NMPA
Ribostamycin Sulfate for Injection
- Product Name
- 注射用硫酸核糖霉素
- Approval Number
- 国药准字H46020474
- Approval Date
- Jul 15, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 16
- Next
Clinical Trials
No trials found
News
No news found